CMS Open Payments · Program Year 2024
TAS Medical, Inc.
TAS Medical, Inc. reported $33,817.24 across General Payments, Research, and Ownership to 298 physicians and teaching hospitals across 298 transactions.
- $33.8K Below-median payer
- All-tracks total
- 298 Above-median volume
- Transactions
- 298 Above-median reach
- Recipients
- #1448
- of 1,925 companies
TAS Medical, Inc. reported $33,817.24 across all CMS Open Payments tracks (General + Research + Ownership) to 298 physicians and teaching hospitals in Program Year 2024 - ranking #1448 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $33,817.24, averaging $113.48 per recipient.
TAS Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
10/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer tas-medical-inc TAS Medical, Inc.
$33.8K · #1448/1,925 · 0.0% industry · PY2024
- TOT $33.8K
- RANK #1448
- SHARE 0.0%
- TXN 298
- RCP 298
- CAT 2
- GEN $33.8K
- TOP1 46.6%
- PY 2024
Volume peers
Nearest volume peer: Prism Medical ($34.0K)
TAS Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for TAS Medical, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For TAS Medical, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
288 transactions worth $20.8K make "Food and Beverage" the top general-payment category in the 2-category breakdown below, 61.6% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
TAS Medical, Inc. made 2 types of general payments. "Food and Beverage" is the largest category at $20.8K, 61.6% of General Payments.
How TAS Medical, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $20.8K | 288 | 61.6% |
| Consulting Fee | $13.0K | 10 | 38.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $21,498.08 (63.6%) of $33,817.24 in this company's General Payments records across 56 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for TAS Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Michael Sawyer
$15,775.34 across 44 reported transactions
- 2
Danielle Louise Cobb
$1,522.30 across 10 reported transactions
- 3
Daryl S Marx
$1,504.22 across 12 reported transactions
- 4
Carlos Egas
$1,422.76 across 20 reported transactions
- 5
Karl Andrew LeBlanc
$1,273.46 across 10 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
TAS Medical, Inc. ranks #1448 of 1,925 by total payments (bottom 25% by spend) but is notably more concentrated than that alone would suggest -- #697 of 1,838 by HHI (top 38% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Canon Healthcare USA, Inc. : $5.3K total payments, HHI 2317
- LENSAR, Inc. : $330.1K total payments, HHI 2312
- Astellas Pharma Inc : $82.8K total payments, HHI 2312
- Beaver-Visitec International, Inc. : $378.1K total payments, HHI 2302
- Scientia Vascular : $184.8K total payments, HHI 2293
- Sumitomo Pharma Co., Ltd. : $121.9K total payments, HHI 2292
- TAS Medical, Inc. (this company) : $33.8K total payments, HHI 2291
- Advanced Oxygen Therapy Inc. : $115.1K total payments, HHI 2288
- Mizuho America, Inc. : $403.0K total payments, HHI 2287
- Lantheus Medical Imaging, Inc. : $1.6M total payments, HHI 2283
- Les Laboratoires Servier : $14.8K total payments, HHI 2263
- BioWound Solutions, Inc. : $24.1K total payments, HHI 2261
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as TAS Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about TAS Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with TAS Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Grifols Biologicals LLC
ZSFab, Inc.
Cycle Pharmaceuticals Inc
MediView XR, Inc.
Olympus Winter & Ibe GmbH
Put this to use
TAS Medical, Inc. ranks #1448 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just TAS Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.